Marwan G. Fakih, MD, explains the implications of the findings from the phase 2 trial of balstilimab plus botensilimab for the treatment of patients with microsatellite stable metastatic colorectal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback